CD8A and neoplasm: IL-2/NARA1 complex1. IL-2 and NARA1 (NARA1, high-affinity CD25 mimic, avoiding vascular leak syndrome caused by Tregs activation);2. In vivo;3. Inhibited tumor growth;4. Expanded tumor-specific CD8+ T cells with better effector function;